The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D’Orazio, T. J.
Right arrow Articles by Niederkorn, J. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D’Orazio, T. J.
Right arrow Articles by Niederkorn, J. Y.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Dietary Proteins
The Journal of Immunology, 2001, 166: 26-32.
Copyright © 2001 by The American Association of Immunologists

Ocular Immune Privilege Promoted by the Presentation of Peptide on Tolerogenic B Cells in the Spleen. II. Evidence for Presentation by Qa-11

Thomas J. D’Orazio*, Elizabeth Mayhew{dagger} and Jerry Y. Niederkorn2,{dagger}

* Graduate Program in Immunology and {dagger} Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX 75235

Ocular immune privilege is the result of several unique features of the eye, including the systemic down-regulation of Th1 immune responses to Ags encountered in the anterior chamber of the eye—a phenomenon termed anterior chamber-associated immune deviation (ACAID). The induction of ACAID requires the participation of three cell populations: the ocular ACAID APC, the splenic B cell, and the splenic T cell. Because B cells have been implicated in tolerogenic Ag presentation in other systems, we hypothesized that B cells were responsible for the induction of regulatory T cells in ACAID. The central hypothesis for this study is that APC from the eye migrate to the spleen where they release antigenic peptides (OVA) that are captured and presented to T cells by splenic B cells. A combination of in vitro and in vivo studies demonstrated that splenic B cells, incubated with ACAID APC in vitro, were capable of inducing ACAID when transferred to naive mice. The induction of ACAID required the normal expression of {beta}2-microglobulin on both the B cell and ACAID APC, but not on the T suppressor cells. Moreover, the induction of ACAID regulatory cells required histocompatibility between the B cells and regulatory T cells at the TL/Qa region. The results indicate that: 1) B cells are necessary for the induction of ACAID; 2) ACAID B cells do not directly suppress the expression of delayed-type hypersensitivity; and 3) the induction of Ag-specific regulatory T cells by ACAID B cells requires histocompatibility at the TL/Qa region.




This article has been cited by other articles:


Home page
Int ImmunolHome page
S. Chattopadhyay, J. O'Rourke, and R. E. Cone
Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells
Int. Immunol., April 1, 2008; 20(4): 509 - 516.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. M. Ashour and T. M. Seif
The role of B cells in the induction of peripheral T cell tolerance
J. Leukoc. Biol., November 1, 2007; 82(5): 1033 - 1039.
[Full Text] [PDF]


Home page
J. Immunol.Home page
H. M. Ashour and J. Y. Niederkorn
{gamma}{delta} T Cells Promote Anterior Chamber-Associated Immune Deviation and Immune Privilege through Their Production of IL-10
J. Immunol., December 15, 2006; 177(12): 8331 - 8337.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. M. Ashour and J. Y. Niederkorn
Peripheral Tolerance Via the Anterior Chamber of the Eye: Role of B Cells in MHC Class I and II Antigen Presentation
J. Immunol., May 15, 2006; 176(10): 5950 - 5957.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Mizoguchi and A. K. Bhan
A Case for Regulatory B Cells
J. Immunol., January 15, 2006; 176(2): 705 - 710.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Zhang-Hoover, P. Finn, and J. Stein-Streilein
Modulation of Ovalbumin-Induced Airway Inflammation and Hyperreactivity by Tolerogenic APC
J. Immunol., December 1, 2005; 175(11): 7117 - 7124.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. Kitaichi, K. Namba, and A. W. Taylor
Inducible immune regulation following autoimmune disease in the immune-privileged eye
J. Leukoc. Biol., April 1, 2005; 77(4): 496 - 502.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Wei, P. Velazquez, O. Turovskaya, K. Spricher, R. Aranda, M. Kronenberg, L. Birnbaumer, and J. Braun
Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets
PNAS, February 8, 2005; 102(6): 2010 - 2015.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Y. Niederkorn, E. Mayhew, J. Mellon, and S. Hegde
Role of Tumor Necrosis Factor Receptor Expression in Anterior Chamber-Associated Immune Deviation (ACAID) and Corneal Allograft Survival
Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2674 - 2681.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Roelofs-Haarhuis, X. Wu, and E. Gleichmann
Oral Tolerance to Nickel Requires CD4+ Invariant NKT Cells for the Infectious Spread of Tolerance and the Induction of Specific Regulatory T Cells
J. Immunol., July 15, 2004; 173(2): 1043 - 1050.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. E. Faunce, A. Terajewicz, and J. Stein-Streilein
Cutting Edge: In Vitro-Generated Tolerogenic APC Induce CD8+ T Regulatory Cells That Can Suppress Ongoing Experimental Autoimmune Encephalomyelitis
J. Immunol., February 15, 2004; 172(4): 1991 - 1995.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. E. Skelsey, E. Mayhew, and J. Y. Niederkorn
Splenic B Cells Act as Antigen Presenting Cells for the Induction of Anterior Chamber-Associated Immune Deviation
Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5242 - 5251.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Roelofs-Haarhuis, X. Wu, M. Nowak, M. Fang, S. Artik, and E. Gleichmann
Infectious Nickel Tolerance: A Reciprocal Interplay of Tolerogenic APCs and T Suppressor Cells That Is Driven by Immunization
J. Immunol., September 15, 2003; 171(6): 2863 - 2872.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. S. Gregerson and C. Dou
Spontaneous Induction of Immunoregulation by an Endogenous Retinal Antigen
Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 2984 - 2991.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.